4
Changes in Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-26-093482
Chief Financial Officer gave up 21,238 shares (to pay taxes)
- Chief Financial Officer acquired 49,995 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Roche Corleen M. · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-06 | Exercise or conversion : show line 1 in the form | +49,995 | 49,995 | D | ||
| 2026-08-06 | Shares withheld for taxes : show line 2 in the form | −21,238 | $6.21 | $131,888 | 28,757 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-08-06 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −49,995 | 100,005 | D |
Loading xslF345X06/tm2622610-1_4seq1.xml…